(*) USA Approval Date: 2015. 11.23.
Company
EU>Approved
Mechanism: PD-1 Inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2018. 10.16.
RCC: Renal Cell Carcinoma
TradeMark
TradeMark Web-Site
UpDate: 2016. 07.09.
USA Approval Press Release